About the article “Metformin, a therapeutic reality in the treatment of gestational diabetes mellitus”

Authors

Keywords:

congenital defects, metformin, epigenetics

Downloads

Download data is not yet available.

Author Biography

Noel Taboada Lugo, Centro Provincial de Genética Médica de Villa Clara

Especialista de I y II Grado en Medicina General Integral. Especialista de I y II Grado en Genética Clínica. Máster en Atención Integral al Niño. Doctor en Ciencias Médicas. Profesor Auxiliar de Genética Médica en la Universidad de Ciencias Médicas de Villa Clara. Investigador Auxiliar.

References

1.Zhang TN, Huang XM, Zhao XY, Wang W, Wen R, Gao SY. Risks of specific congenital anomalies in offspring of women with diabetes: A systematic review and meta-analysis of population-based studies including over 80 million births. PLoS Med [Internet]. 2022 [citado 03/06/2022];19(2):e1003900. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806075/. https://doi.org/10.1371/journal.pmed.1003900

2.Taboada Lugo N. Papel del ácido fólico, zinc y cobre en la prevención primaria de los defectos congénitos. Rev Cubana Med Gen Integr [Internet]. 2016 [citado 03/06/2022];32(4):[aprox. 9 p.]. Disponible en: https://revmgi.sld.cu/index.php/mgi/article/view/167/110

3.Taboada Lugo N, Herrera Martinez M. Mecanismos epigenéticos y vía de señalización Notch en el origen de diferentes defectos congénitos. Medicentro Electrónica [Internet]. 2018 [citado 03/06/2022];22(3):197-207 Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30432018000300002

4.Lindsay RS, Loeken MR. Metformin use in pregnancy: promises and uncertainties. Diabetologia [Internet]. 2017 [citado 03/06/2022];60:1612-1619. Disponible en: https://link.springer.com/content/pdf/10.1007/s00125-017-4351-y.pdf. https://doi.org/10.1007/s00125-017-4351-y

5.Taboada Lugo N. Factores epigenéticos involucrados en el origen de defectos congénitos relacionados con la deficiencia materna de ácido fólico y otros micronutrientes. Acta Méd Centro [Internet]. 2019 [citado 03/06/2022];13(3):439-454. Disponible en: https://revactamedicacentro.sld.cu/index.php/amc/article/view/937/1295

6.Dai C, Fei Y, Li J, Shi Y, Yang X. A novel review of homocysteine and pregnancy complications. BioMed Res Int [Internet]. 2021 [citado 03/06/2022]:2021:6652231. Disponible en: https://www.hindawi.com/journals/bmri/2021/6652231/. https://doi.org/10.1155/2021/6652231

7.Shi H, Yang S, Lin N, Huang P, Yu R, Chen M, et al. Study on maternal SNPs of MTHFR gene and HCY level related to congenital heart diseases. Pediatric Cardiol [Internet]. 2021 [citado 03/06/2022];42(1):42-46. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864808/. https://doi.org/10.1007/s00246-020-02449-1

8.Hernández Parets M, Brito Ferrer Y, Zayas González M. Metformina, una realidad terapéutica en el tratamiento de la diabetes mellitus gestacional. Acta Méd Centro [Internet]. 2022 [citado 03/06/2022];16(2):374-377. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S2709-79272022000200374

9.Brand KMG, Saarelainen L, Sonajalg J, Boutmy E, Foch C, Vääräsmäki M, et al. Metformin in pregnancy and risk of adverse long-term outcomes: a register-based cohort study. BMJ Open Diabetes Res Care [Internet]. 2022 [citado 03/06/2022];10(1):e002363. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734020/. https://doi.org/10.1136/bmjdrc-2021-002363

Downloads

Published

2023-04-04

How to Cite

1.
Taboada Lugo N. About the article “Metformin, a therapeutic reality in the treatment of gestational diabetes mellitus”. Acta Méd Centro [Internet]. 2023 Apr. 4 [cited 2025 Jul. 3];17(2):359-62. Available from: https://revactamedicacentro.sld.cu/index.php/amc/article/view/1735

Issue

Vol. 17 No. 2 (2023): Abril-Junio

Section

Letters to the Editor

License

Authors who have publications with this journal agree to the following terms:

  1. Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
  2. Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
  3. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).